Figure 1 Associations between baseline cerebrospinal fluid

Slides:



Advertisements
Similar presentations
Immune Reconstitution Inflammatory Syndrome (IRIS)
Advertisements

Cryptococcal IRIS: Pathogenesis & Pearls for Clinical Management
Julio A. Ramirez, MD, FACP Professor of Medicine Chief, Infectious Diseases University of Louisville Chief, Infectious Diseases Veterans Affairs Medical.
≥18 years HIV+, cART-naïve First CM Intensive Ampho 14 d Consolidation 400mg Fluconazole 12 weeks Maintenance 200mg Fluconazole therapy W02 W04 W08 W12.
1 Cluster of differentiation molecules.. 2 CELLSCD Number Macrophages, monocyte CD4, CD11b, CD64, CD115, CD86 (B7-2), CD80 (B7 – 1) Dendritic cell CD1a,
BDNF: brain-derived neurotrophic factor CRP: C-reactive protein
Regulation of human cytokines by Cordyceps militaris
Nat. Rev. Neurol. doi: /nrneurol
Figure 4 Paradoxical immune reconstitution inflammatory syndrome
Figure 4 Host damage from infection-related inflammatory
Figure 1 Radiation-induced effects on tumour cells
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 2 Systemic immune responses to cryptococcal antigen
Cerebrospinal fluid cytokines in enterovirus 71 brain stem encephalitis and echovirus meningitis infections of varying severity  S.-M. Wang, H.-Y. Lei,
Surgical removal of endometriotic lesions alters local and systemic proinflammatory cytokines in endometriosis patients  Stephany P. Monsanto, M.Sc.,
The role of viruses in acute exacerbations of asthma
S. S. Pullamsetti, R. Savai, W. Janssen, B. K. Dahal, W. Seeger, F
Figure 2 Main functions of IL-1
Cytokine and chemokine expression of flucloxacillin-specific T cell clones (TCC) of patient P1. Cytokine and chemokine expression of flucloxacillin-specific.
Nat. Rev. Neurol. doi: /nrneurol
Figure 5 Corticosteroid treatment can reduce brain
Figure 1 The central role of chronic prostate
Paradoxical immune reconstitution inflammatory syndrome associated with cryptococcal meningitis in China: a 5-year retrospective cohort study  S. Yan,
Cryptococcal Immune Reconstitution Inflammatory Syndrome
Volume 22, Issue 6, Pages (June 2014)
Supplementary Figure legends
The pro-inflammatory and chemotactic cytokine microenvironment of the abdominal aortic aneurysm wall: A protein array study  Rachel K. Middleton, BSc,
Nat. Rev. Neurol. doi: /nrneurol
Figure 6 Schematic of an analysis of a new biopsy
Aromatase is required for female abdominal aortic aneurysm protection
Inflammatory cytokine levels in chronic venous insufficiency ulcer tissue before and after compression therapy  Stephanie K. Beidler, MD, Christelle D.
Figure 4 Lifestyle and environmental factors affect
Figure 1 Evolution of multiple sclerosis
Young and Aged Blunt Trauma Patients Display Major Differences in Circulating Inflammatory Mediator Profiles after Severe Injury  Ashley J. Lamparello,
Pg and Ec LPS induced levels of soluble mediators from in cultures of individuals with and without T2D with periodontitis. Pg and Ec LPS induced levels.
Cryptococcal Immune Reconstitution Inflammatory Syndrome
L. Y. A. Chai, R. Naesens, A. L. Khoo, M. V. Abeele, K
Figure 3 Current model of immunopathogenesis in CIDP
Figure 2 Logistical requirements for autologous
BALB/c scid mice have higher levels of macrophage-stimulating cytokines in circulation compared with BALB/c control mice. BALB/c scid mice have higher.
Inflammatory health effects of indoor and outdoor particulate matter
John T. Chang, William J. Sandborn  Gastroenterology 
Figure 1 Cytokine titers determined by the multiplex bead assay Plotted are cytokine titers (pg/mL) in CSF of patients with other noninflammatory neurologic.
Genomic and proteomic determinants of lower extremity revascularization failure: Rationale and study design  Peter R. Nelson, MD, Kerri A. O’Malley, PhD,
Effects of Statins on Renal Function
Y. -P. Ding, M. -F. Liang, J. -b. Ye, Q. -h. Liu, C. -h. Xiong, B
F.L. van de Veerdonk, B.-J. Kullberg, M.G. Netea 
Figure 2 GM-CSF — a key player in inflammation and autoimmunity
Unstimulated levels of soluble mediators from in cultures of individuals with and without T2D with periodontitis. Unstimulated levels of soluble mediators.
Figure 3 Responder subset (A) Percentage of “responders” (nonprogressing patients) at week 25 after 6 months of treatment; percentage of “responders” in.
Holger Lawall, MD, Peter Bramlage, MD, PhD, Berthold Amann, MD 
Profiles of anti-inflammatory cytokines after endotoxin injection.
Combination extract inhibits immune responses in vivo.
Nat. Rev. Neurol. doi: /nrneurol
Figure 3 Rett syndrome severity and age at diagnosis by mutation type
Romain Gallet et al. BTS 2016;1:14-28
Nat. Rev. Neurol. doi: /nrneurol
Immune reconstitution inflammatory syndrome (IRIS) associated with Mycobacterium tuberculosis (TB) infection. a) In healthy individuals in response to.
Figure 5 ADP-induced inflammatory responses require P2Y12 receptors in human microgliaIncreasing concentrations of ADP (5, 50, and 200 μM) increased tumor.
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 4 Role of chemokines in dendritic cell migration
Lec.9 Cytokines.
Figure 4 Alemtuzumab-mediated effects on interleukin (IL)–23 and granulocyte-macrophage colony-stimulating factor (GM-CSF) production in innate myeloid.
Figure 1 The role of macrophages in RA
Mechanisms of virus-induced airway inflammation in chronic obstructive pulmonary disease (COPD). Mechanisms of virus-induced airway inflammation in chronic.
Figure 2 Effect of DMF therapy on the T helper cell repertoire and cytokine production Effect of DMF therapy on the T helper cell repertoire and cytokine.
Induction of immune mediators and growth factors upon stimulation with pro-inflammatory cytokines. Induction of immune mediators and growth factors upon.
Schematic model illustrating how paracrine signaling drives LPS-stimulated cytokine secretion. Schematic model illustrating how paracrine signaling drives.
Figure 3 The possible role of keratinocytes in CRPS pathophysiology
ADU-S100 primes the innate immune system in tolerant, tumor bearing neu/N mice. ADU-S100 primes the innate immune system in tolerant, tumor bearing neu/N.
Presentation transcript:

Figure 1 Associations between baseline cerebrospinal fluid immune response profiles and clinical outcome in HIV-associated CM Figure 1 | Associations between baseline cerebrospinal fluid immune response profiles and clinical outcome in HIV-associated CM. Baseline cerebrospinal fluid (CSF) cytokine and chemokine concentrations were measured in 90 patients with HIV-associated cryptococcal meningitis (CM). Principal component analysis was used to identify co-correlated cytokine and chemokine measurements that accounted for the variance in the cytokine data set. A majority of this variance was accounted by two components, PC1 and PC2. PC1 was driven by increased levels of IL-6 and IFN-γ, and also IL-8, IL-10, CCL5 (also known as RANTES), tumour necrosis factor (TNF), and IL-17. PC2 was driven by high concentrations of chemokines, monocyte chemotactic protein 1 (MCP-1) and macrophage inflammatory protein 1α (MIP-1α), and granulocyte- macrophage colony stimulating factor (GM-CSF). a | PC1 score was associated with 2-week survival. b | In those who survived and were started on antiretroviral therapy, PC2 score was associated with the development of CM-associated immune reconstitution inflammatory syndrome (IRIS). The points on the graphs represent the mean values, and the error bars denote standard errors of the mean. Reproduced from Jarvis, J. N. et al. Cerebrospinal fluid cytokine profiles predict risk of early mortality and immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis. PLoS Pathog. 11, e1004754 (2015); used under CC BY: http://creativecommons.org/licenses/by/2.0/legalcode. Reproduced from Jarvis, J. N. et al. Cerebrospinal fluid cytokine profiles predict risk of early mortality and immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis. PLoS Pathog. 11, e1004754 (2015); used under CC BY: http://creativecommons.org/ licenses/by/2.0/legalcode. Williamson, P. R. et al. (2016) Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy Nat. Rev. Neurol. doi:10.1038/nrneurol.2016.167